SOLOSEC

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Sep 15, 2017

   8 yr 11 mo ago

2. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Sep 15, 2022

   3 yr 10 mo ago

3. Today

4. Exclusivity ends · GAIN

   Qualified infectious disease product exclusivity (adds 5 years)

   Sep 15, 2027

   in 1 yr 3 mo

5. Patent 10335390 expires

   Listed drug product patent expiration.

   Sep 04, 2035

   in 9 yr 4 mo

6. Patent 10335390 expires

   Listed drug product patent expiration.

   Sep 04, 2035

   in 9 yr 4 mo

7. Patent 10682338 expires

   Listed drug product patent expiration.

   Sep 04, 2035

   in 9 yr 4 mo

8. Patent 10682338 expires

   Listed drug product patent expiration.

   Sep 04, 2035

   in 9 yr 4 mo

9. Patent 10849884 expires

   Listed drug product patent expiration.

   Sep 04, 2035

   in 9 yr 4 mo

10. Patent 10849884 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

11. Patent 10849884 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

12. Patent 10849884 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

13. Patent 10857133 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

14. Patent 10857133 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

15. Patent 11000507 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

16. Patent 11000507 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

17. Patent 11000507 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

18. Patent 11000507 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

19. Patent 11000508 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

20. Patent 11000508 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

21. Patent 11000508 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

22. Patent 11000508 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

23. Patent 11020377 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

24. Patent 11020377 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

25. Patent 11020377 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

26. Patent 11020377 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

27. Patent 11324721 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

28. Patent 11324721 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

29. Patent 11324721 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

30. Patent 11324721 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

31. Patent 11602522 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

32. Patent 11602522 expires

    Listed drug product patent expiration.

    Sep 04, 2035

    in 9 yr 4 mo

33. Patent 11684607 expires

    Listed drug product patent expiration.

    Sep 16, 2035

    in 9 yr 5 mo

34. Patent 11684607 expires

    Listed drug product patent expiration.

    Sep 16, 2035

    in 9 yr 5 mo

35. Patent 11684607 expires

    Listed drug product patent expiration.

    Sep 16, 2035

    in 9 yr 5 mo

36. Patent 11684607 expires

    Listed drug product patent expiration.

    Sep 16, 2035

    in 9 yr 5 mo

37. Patent 12280037 expires

    Listed method-of-use patent (U-3302) expiration.

    Dec 11, 2041

    in 15 yr 8 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• NCENew chemical entity exclusivity (5 years)

  Sep 15, 2022

  3 yr 10 mo ago

• GAINQualified infectious disease product exclusivity (adds 5 years)

  Sep 15, 2027

  in 1 yr 3 mo

Listed patents (33)